Your browser doesn't support javascript.
loading
Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.
Vornov, J J; Hollinger, K R; Jackson, P F; Wozniak, K M; Farah, M H; Majer, P; Rais, R; Slusher, B S.
Afiliação
  • Vornov JJ; Johns Hopkins School of Medicine, Baltimore, MD, United States; Medpace, Cincinnati, OH, United States.
  • Hollinger KR; Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Jackson PF; Janssen Pharmaceuticals, San Diego, CA, United States.
  • Wozniak KM; Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Farah MH; Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Majer P; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
  • Rais R; Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Slusher BS; Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: bslusher@jhmi.edu.
Adv Pharmacol ; 76: 215-55, 2016.
Article em En | MEDLINE | ID: mdl-27288079

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Glutâmico / Glutamato Carboxipeptidase II / Dipeptídeos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Glutâmico / Glutamato Carboxipeptidase II / Dipeptídeos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article